RXRA and malignant colon neoplasm: To further explore the possibility that EGCG could reverse RXRα loss of expression in human colon cancer, we tested the ability of EGCG to suppress proliferation in several human colon cancer cell lines, chosen for differences in their molecular phenotypes.